Tarsadia Capital, LLC — 13F Portfolio

Tarsadia Capital, LLC is an Irvine, California-based private investment firm operating primarily as a family office and principal investment vehicle. Founded by entrepreneur and investor Hasmukh C. Patel, the firm manages proprietary capital with a long-term orientation and concentrated focus on high-quality businesses across public and private markets. As a qualifying institutional investment manager, Tarsadia Capital files quarterly 13F reports with the Securities and Exchange Commission under CIK #0001777371, disclosing its long equity positions in U.S.-traded securities and providing transparency into its public market investment strategy. Hasmukh C. Patel brings extensive entrepreneurial and investment experience to the firm's leadership, having founded and built successful businesses across multiple industries. This operating background informs Tarsadia Capital's investment philosophy, emphasizing deep understanding of business fundamentals, competitive positioning, and management quality. The firm's family office structure allows for patient capital deployment unconstrained by external redemption pressures or short-term performance benchmarking, enabling a truly long-term investment horizon and willingness to maintain concentrated positions in highest-conviction opportunities. The firm's Southern California location in Irvine positions it within Orange County's entrepreneurial ecosystem and provides proximity to technology and consumer innovation centers throughout the broader California region. Tarsadia Capital's 13F filing history offers a window into its public equity positioning, revealing sector preferences, position sizing discipline, and portfolio evolution across market cycles. These quarterly disclosures capture reportable long positions, though they represent only one component of the firm's broader investment activities, which may include private equity, venture capital, real estate, and other alternative asset classes not subject to 13F reporting requirements.

Tarsadia Capital employs a concentrated, growth-oriented investment strategy focused on identifying exceptional businesses with sustainable competitive advantages and long runway growth prospects. The firm's approach emphasizes quality over quantity, maintaining focused portfolios of carefully researched companies rather than broad diversification across hundreds of positions. This conviction-weighted methodology reflects confidence in fundamental research capabilities and willingness to let winners compound over extended holding periods without artificial position size constraints. The firm's 13F Portfolio Composition typically reveals meaningful exposure to technology, healthcare, and consumer-oriented sectors, reflecting focus on industries undergoing structural growth tailwinds and secular transformation. Position sizing suggests concentrated allocation to highest-conviction ideas, with the firm comfortable maintaining outsized positions in companies meeting its quality, growth, and valuation criteria. This approach introduces concentration risk but aligns with the family office mandate prioritizing long-term wealth compounding over short-term volatility minimization or benchmark tracking. Tarsadia Capital's investment philosophy centers on identifying businesses with durable competitive moats—network effects, switching costs, brand strength, regulatory barriers, or proprietary technology—that protect market positions and enable sustained above-market growth rates. The firm evaluates management teams extensively, seeking leaders with proven execution capability, aligned incentives through meaningful ownership stakes, and strategic vision for navigating competitive landscapes. This emphasis on management quality reflects the view that exceptional leaders create disproportionate value over time through capital allocation excellence and operational execution. The Top 10 Holdings Concentration metric provides quantitative insight into the firm's conviction-weighted approach, likely revealing significant capital allocation to a relatively small number of core positions. This concentrated structure amplifies both upside capture when thesis accuracy proves correct and downside exposure when individual investments disappoint, creating performance profiles distinct from diversified index-tracking strategies. For investors analyzing Tarsadia Capital's approach, understanding this concentration dynamic proves essential for calibrating expectations around volatility, drawdown potential, and alpha generation patterns. Portfolio turnover characteristics suggest a low-to-moderate trading pace consistent with long-term holding period orientation. The firm appears willing to maintain core positions across multiple years as fundamental theses play out, avoiding excessive trading that introduces transaction costs and short-term noise. However, the concentrated structure requires ongoing thesis validation and willingness to exit positions when fundamental deterioration occurs, competitive dynamics shift unfavorably, or valuations reach levels offering insufficient forward return potential. This disciplined approach to both position initiation and exit proves critical for concentrated portfolio success over full market cycles.

Tarsadia Capital, LLC represents a concentrated, growth-oriented family office investment platform led by entrepreneur and principal Hasmukh C. Patel. The firm's Irvine base and principal capital structure enable truly long-term investment horizons and conviction-weighted positioning unconstrained by typical institutional mandates or liquidity requirements. Quarterly 13F filings document the firm's public equity holdings, revealing focused portfolios emphasizing quality growth businesses across technology, healthcare, and consumer sectors. For performance analysts evaluating the firm's approach, the Annualized Return (CAGR) metric synthesizes compounding behavior over extended periods, though absolute return figures must be evaluated in context of the significant volatility and concentration risk inherent in the strategy. The Sortino Ratio provides additional perspective by focusing specifically on downside deviation rather than total volatility, offering nuanced insight into whether upside capture during favorable periods has adequately compensated for loss exposure during corrections. Historical replication through portfolio backtesting services enables empirical assessment of how the firm's disclosed 13F positions would have performed across different market regimes—growth equity bull markets, value rotations, rising rate environments, and recessionary periods. This regime-dependent analysis proves essential for understanding when concentrated growth strategies add value and when they face structural headwinds, informing forward-looking allocation decisions based on macroeconomic outlook and market cycle positioning. The firm's concentrated positioning and growth orientation create pronounced regime sensitivity, with performance highly dependent on growth equity valuations, investor risk appetite, and individual company execution. During periods of abundant liquidity, low interest rates, and momentum-driven markets, the strategy typically captures significant upside from both multiple expansion and fundamental growth. However, shifting monetary policy, rising discount rates, or rotation toward profitability and cash flow generation can trigger sharp reversals in growth equity valuations, introducing substantial drawdown risk amplified by concentration. Sector Allocation History provides longitudinal documentation of how Tarsadia Capital's industry exposures have evolved, revealing whether the firm maintains consistent sector emphasis or tactically adjusts positioning based on relative value assessment and macroeconomic outlook. The concentrated structure suggests strategic conviction rather than tactical sector rotation drives allocation decisions, with portfolio composition reflecting long-term views on structural growth opportunities rather than short-term market timing. How has Tarsadia Capital's portfolio concentration and position-level sizing discipline historically responded to periods of elevated growth equity valuations and subsequent corrections, and what does this reveal about the firm's willingness to moderate exposure during frothy markets versus maintaining strategic conviction through full volatility cycles?

Tarsadia Capital's risk characteristics stem directly from its concentrated, growth-oriented mandate and family office structure. The portfolio exhibits elevated Volatility Profile relative to diversified blend strategies, with returns subject to significant fluctuations driven by individual position performance and growth equity sentiment cycles. Concentrated portfolios naturally experience wider performance dispersion, with outsized gains during favorable periods offset by potential for substantial drawdowns when core holdings face execution challenges, competitive pressures, or broader market derating of growth valuations. Max Drawdown Depth becomes particularly relevant for evaluating concentrated growth strategies, as portfolio outcomes depend heavily on a small number of positions. Historical peak-to-trough declines provide empirical context for worst-case scenarios investors might experience, informing assessment of whether the strategy's risk profile aligns with personal loss tolerance and liquidity requirements. The family office structure suggests capacity to withstand significant temporary capital impairment without forced selling, but external investors analyzing the approach must evaluate their own ability to maintain positions through volatile periods. Downside capture characteristics likely reflect the portfolio's growth orientation and technology sector exposure, with elevated sensitivity to rising interest rate environments and risk-off market sentiment. Growth-focused portfolios typically experience amplified losses during broad market corrections, particularly when selloffs are driven by multiple compression rather than fundamental deterioration. The firm's Sharpe Ratio contextualizes whether absolute returns have adequately compensated for elevated volatility assumption, while downside deviation metrics provide additional nuance on loss distribution patterns. Concentration risk extends beyond individual position exposure to correlated factor risks. Technology and healthcare growth stocks often exhibit similar sensitivity to interest rate changes, liquidity conditions, and economic growth expectations, potentially reducing diversification benefits during systematic market dislocations. The firm's quality bias toward competitively advantaged businesses with strong balance sheets may provide some defensive characteristics, though growth equity valuation sensitivity to discount rate changes remains a structural vulnerability during monetary tightening cycles. Risk management in concentrated portfolios centers on deep fundamental research, ongoing thesis monitoring, and conviction-based position sizing rather than portfolio-level diversification or hedging strategies. Tarsadia Capital's family office structure and principal capital base allow for true long-term orientation unconstrained by external redemption pressures, potentially enabling superior decision-making during periods of temporary market dislocation when forced sellers create opportunity for patient capital. However, this same structure means performance outcomes depend heavily on a small number of high-conviction decisions, amplifying the importance of research accuracy and judgment quality.